BioTime proposes follow-on

BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date announced: 10/28/13 Type: Follow-on To be raised: Up to $15 million Units: TBD Price: TBD Note: BioTi...